Legislation

Title: Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting
Sponsored by: Senators Hayes and Hershey
Status: In the Senate - Hearing 3/06 at 1:00 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health's website based on the information the Secretary receives under certain provisions of the Act; etc.

Committees

Original:: Finance Click to view Recorded Media

Details

Cross-filed with: HB0920

Bill File Type: Regular

Effective Date(s): October 1, 2019

History

Legislation History
Chamber Senate Calendar Date 2/04/2019 Legislative Date 2/04/2019 Action First Reading Finance Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting Proceedings
Chamber Senate Calendar Date 2/11/2019 Legislative Date 2/11/2019 Action Hearing 3/13 at 1:00 p.m. Proceedings
Chamber Senate Calendar Date 2/18/2019 Legislative Date 2/18/2019 Action Hearing canceled Proceedings
Chamber Senate Calendar Date 2/18/2019 Legislative Date 2/18/2019 Action Hearing 3/06 at 1:00 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
Senate	2/04/2019	2/04/2019	First Reading Finance
			Text - First - Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting
Senate	2/11/2019	2/11/2019	Hearing 3/13 at 1:00 p.m.
Senate	2/18/2019	2/18/2019	Hearing canceled
Senate	2/18/2019	2/18/2019	Hearing 3/06 at 1:00 p.m.

File Code

Subjects

Statutes